
Start a Technology to collaborate on new research.
Technologies are open to all Therapoid members, subject to the our Terms of Service (TOS). You can utilize these technologies in your research free of charge with other Therapoid users.

-
A549 Cells: Lung Carcinoma Cell Line for Adenovirus
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This is a cell line derived from explanted cultures of human lung cancer tissue. This cell line has been tested by the FDA.
Tags: oncolytics cancer virus A549 Cells adenoviruses Lung Cancer RCA E1A lung -
A novel class of antitumor amphiphilic amines (RCn)
Provided by:
Research Institute Nationwide Children's Hospital; University of Bologna
Category:
Open Technologies
A novel class of amphiphilic amines (RCn) as antitumor agents and nanocarriers.
Tags: cancer amines amphiphilic -
A platform to discover essential proteins as potential antibiotic targets
Provided by:
Bacmine™; Open Therapeutics™
Category:
Open Technologies
Discover new therapeutic targets against antibiotic resistant pathogens to identify novel antibiotic targets.
Tags: biopharma Essential proteins -
Assay to Screen Anti-metastatic Drugs
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology pertains to molecular mechanisms and/or signaling pathways involved in tumorigenesis, angiogenesis and metastasis of breast cancer and its response to therapy.
Tags: GFP Breast Cancer Angiogenesis tumorigenesis Cell Line Murine Mammary tumors -
BODIPY-FL Nilotinib (Tasigna) for Use in Cancer Research
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology pertains to bodipy conjugated tyrosine kinase inhibitors that are currently used in the clinic for the treatment of CML or gastric cancers.
Tags: Tyrosine Kinase Inhibitor TKI Tasigna Nilotinib BODIPY Gastric Cancers CML -
Cell lines Expressing Nuclear and/or Mitochondrial RNAse H1
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology pertains to small molecule inhibitors of RNase H1, especially in regards to genome instability, transcription, and translation.
-
Combined raman spectroscopy-optical coherence tomography (RS-OCT) system and applications of the same
Provided by:
The Center for Advancing Innovation; Vanderbilt University
Category:
Open Technologies
This technology provides a non-invasive way to diagnose skin cancers, either benign or malignant.
Tags: skin cancer spectroscopy Raman optical coherence tomography Raman Spectroscopy -
Compositions and methods for cancer treatment using targeted carbon nanotubes
Provided by:
The Center for Advancing Innovation
Category:
Open Technologies
This technology describes the specific detection and destruction of tumor cells using photodynamic therapy, with a focus on breast cancer.
Tags: photodynamic therapy carbon nanotubes Breast Cancer tumor vasculature destruction -
Development of wildtype and knockout brain endothelial reporter cells
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology pertains to safe and effective TEM5 agonists and/or antagonists that modulate WNT signaling.
Tags: Wnt catenin TEM5 GPR 124 Wnt signaling inhibitors -
Device for Growing Mammalian Cells on EM Grids
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology is a device used to hold transmission electron microscopy grids that allows adherent mammalian cells to grow.
Tags: Electron Microscopy EM 3D printing TEM -
Differential DNA methylation in diagnosis and treatment of osteoarthritis
Provided by:
Oklahoma Medical Research Foundation (OMRF)
Category:
Open Technologies
DNA methylation profiling of many genes that have been identified for use in diagnosis and staging of osteoarthritis, as well as prognostication of future propensity to develop osteoarthritis
Tags: epigenetics OA Osteoarthritis CpG sites DNA methylation degenerative joint disease -
Engineered Pseudomonas aeruginosa
Provided by:
Bacmine™; Open Therapeutics™
Category:
Open Technologies
Engineered Pseudomonas for biotechnological applications
-
Engineered Pseudomonas aeruginosa for Cholesteatoma treatment
Provided by:
Bacmine™; Open Therapeutics™; University of Cincinnati
Category:
Open Technologies
Engineer new Pseudomonas aeruginosa that specifically target and destroy cholesteatoma cells.
-
Engineered Pseudomonas aeruginosa for wastewater-to-value (a.k.a. Pilus Energy)
Provided by:
Bacmine™; Open Therapeutics™; University of Alberta; University of Cincinnati
Category:
Open Technologies
The genetically enhanced Pseudomonas aeruginosa transforms wastewater into electricity and valuable byproducts.
-
Engineered Talen proteins with enhanced nuclear localization
Provided by:
Oklahoma Medical Research Foundation (OMRF)
Category:
Open Technologies
This technology has to a non-naturally occurring nucleic acid molecule with a sequence encoding a peptide or a DNA-binding polypeptide; including a nucleic acid binding domain and more.
Tags: nucleic acid binding domain subdomain peptide polypeptide DNA-binding -
Establishment of Induced Pluripotent Stem Cells (iPSC) from the Thirteen-lined Ground Squirrel
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology pertains to a ground squirrel iPSC line that can be differentiated into many different cell types for hibernation studies, disease modeling, and drug screening.
Tags: Induced Pluripotent Stem Cells iPSC Squirrel Hibernation Cellular stress Neural injury -
Fenretinide-carrier complexes with enhanced bioavailability
Provided by:
University of Bologna
Category:
Open Technologies
The new fenretinide-carrier molecules soluble-in- water complexes.
Research is underway with pediatric DIPG. -
Fluorescent probes for detection of copper in cells and living organisms
Provided by:
The Center for Advancing Innovation; University of California - Berkeley
Category:
Open Technologies
This technology provides a method that is used to detect copper in living cells in humans.
Tags: fluorescence Copper Cu cofactor fluorescent sensory -
GATA-3 Reporter Plasmids for Revealing Underlying Mechanisms in Breast Cancer
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology pertains to GATA-3 function and dysregulation during the onset and progression of breast cancer that may lead to new strategies in diagnosing and treating the disease.
Tags: diagnostics Breast Cancer Tumor Suppressor GATA-3 prognostics -
Genetically Engineered Mouse-Derived Allograft for Preclinical Studies of Metastatic Melanoma
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology pertains to an allograft that resembles human-like melanoma and has features that will stimulate a normal immunological response in the mouse.
Tags: anti-cancer Melanoma GDA Metastasis Allograft Genetically engineered mice-derived allograft GEM-GDA Preclinical Model -
Genetics Rights Management (GeRM)
Provided by:
Bacmine™; Open Therapeutics™
Category:
Open Technologies
GeRM protects genetically modified organisms from unauthorized use or release into the environment
Tags: GMO lock key risk protection -
High-throughput Assay to Identify New Cancer Drugs
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology provides a diagnostic tool that can identify new drugs that increase chromosome instability.
Tags: GFP Chromosome instability CIN high-throughput assay HAC human artificial chromosome -
Human Antibody for Deploying CH2-Based Therapeutics
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology pertains to a human antibody that could be used safely in vitro and in vivo for the detection of CH2, Fc, and IgG.
Tags: CH2 IgG effector functions conformational epitope nanoantibodies -
Immunocompetent Mouse Model for Tracking Cancer Progression
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology pertains to transgenic mice that have immunocompetent rat growth hormone-firefly Luciferase-enhanced green fluorescent protein (GFP) for use in tracking tumor progression.
Tags: anti-cancer Rat growth hormone Achondroplasia Bioimaging Immunocompetence tumor progression -
Immunogenic memapsin 2 β-secretase peptides and methods of use
Provided by:
Oklahoma Medical Research Foundation (OMRF)
Category:
Open Technologies
Pertaining to antibodies which specifically bind to immunogenic memapsin 2 β-secretase peptides used in treatment of Alzheimer's disease and memapsin 2 β-secretase disorders
Tags: β-amyloid plaques Alzheimer's disease immunogenic compositions memapsin 2 β-secretase -
Improved Antibodies Against ERBB4/HER4
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology pertains to specific rabbit monoclonal antibodies generated against the ErbB4 receptor (also known as HER4) that have been validated for specificity using tissue sections and extracts from ErbB4 knockout mice.
-
Improved Production of Prenylated Protein in Insect Cells
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology pertains to research materials for improved production of prenylated proteins.
Tags: KRAS Ras prenylation -
In vivo visualization of lymphatic tissue
Provided by:
The Center for Advancing Innovation; University of California - Berkeley
Category:
Open Technologies
This technology provides a method for live imaging of lymphatic tissues.
Tags: immunohistochemistry lymphatic tissue lymphatic vessels live imaging -
Knockout and Conditional Knockout Mice-GPR116
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology pertains to surfactant modulating agents for the treatment of surfactant related lung disorders.
Tags: G-protein coupled receptor GPCR Acute Respiratory Distress Syndrome ARDS GPR116 acute lung injury lung surfactant homeostasis -
Lentiviral Vectors with Dual Fluorescence/Luminescence Reporters
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology pertains to twelve lentiviral vectors that express both fluorescent and luminescent markers as a single fusion protein under various gene promoters.
-
Metastatic ovarian cancer mouse models and cell lines for preclinical studies
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology features a Serous Epithelial Ovarian Cancer (SEOC) genetically engineered mouse model (GEM), GEM-derived SEOC orthotopic mouse model, and biological materials derived therefrom.
Tags: anti-cancer GDA GEM Genetically Engineered Mouse Model GEM Derived Allograft Mouse Model Ovarian Cancer SEOC Serous Epithelial Ovarian Cancer -
Method and device for generating a tunable array of fluid gradients
Provided by:
The Center for Advancing Innovation; University of Arizona
Category:
Open Technologies
This technology describes methods for generating gradients that offer unique profile intensities, unique profile shapes, or tunability.
Tags: spatio-temporal control chemical reactions biochemical reactions concentration gradients gradients surface processing -
Method of Diagnosis in Inflammatory Bowel Disease
Provided by:
Oklahoma Medical Research Foundation (OMRF)
Category:
Open Technologies
Methods for diagnostic assays via the detection of carbohydrate antigens and associated autoantibodies that are indicative of the presence of IBD's, such as ulcerative colitis or Crohn's Disease.
Tags: inflammatory bowel disease IBD glycobiology o-glycan Crohn's disease ulcerative colitis carbohydrate antigen autoantibodies -
Methods and compositions for inhibiting fungal infection and disease
Provided by:
Oklahoma Medical Research Foundation (OMRF)
Category:
Open Technologies
This technology pertains to unique agents that target fungal invasion processes.
Tags: antibodies secreted aspartic proteases SAPs Candida albicans RGD-like binding motifs peptides integrins -
Methods and compositions for inhibiting neddylation of proteins
Provided by:
St. Jude Children's Research Hospital; The Center for Advancing Innovation
Category:
Open Technologies
This technology describes the inhibition of NEDD8 activity by inhibiting the binding of NEDD8 E2 enzymes using small molecules and peptides to treat cancer.
Tags: anti-cancer NEDD8 inhibition neddylation E2 enzymes cell growth inhibition -
Methods and compositions for modulating lymphangiogenesis
Provided by:
The Center for Advancing Innovation; University of California - Berkeley
Category:
Open Technologies
This technology describes a novel combination of chemicals that may be used for corneal transplants.
Tags: VEGF inhibition integrin inhibition lymphangiogenesis -
Methods and compositions for the diagnosis and treatment of Ewing's sarcoma
Provided by:
The Center for Advancing Innovation
Category:
Open Technologies
This technology describes a specific diagnostic tool and potential therapeutic target for Ewing's sarcoma.
Tags: Biomarkers Ewing's sarcoma NKX2.2 gene diagnostic tool therapeutic candidate -
Methods and compositions for the treatment of bcr-abl positive lymphoblastic leukemia's
Provided by:
St. Jude Children's Research Hospital; The Center for Advancing Innovation
Category:
Open Technologies
This technology describes a method of treatment for adult and pediatric Ph+ ALL.
Tags: drug combinations BCR-ABL kinase inhibitor lymphoblastic leukemia -
Methods for determining the severity of Sjögren's syndrome and related conditions
Provided by:
Oklahoma Medical Research Foundation (OMRF)
Category:
Open Technologies
This technology relates to compositions and methods for treating some autoimmune diseases, mainly Sjögren's syndrome.
Tags: autoantibodies anti-TRIM 38 Sjögren's Syndrome Endogenous B7 molecule CTLA4 molecule -
Methods for overcoming glucocorticoid resistance and for determining glucocorticoid resistance potential in cancer
Provided by:
St. Jude Children's Research Hospital; The Center for Advancing Innovation
Category:
Open Technologies
This technology treats glucocorticoid resistant cancers, particularly acute Lymphoblastic Leukemia. This technology also includes a diagnostic tool.
Tags: glucocorticoids Acute Lymphoblastic Leukemia ALL glucocorticoid resistance CASP1 inhibition -
Methods for producing autologous immune cells resistant to myeloid-derived suppressor cells effects
Provided by:
The Center for Advancing Innovation
Category:
Open Technologies
This technology focuses on a treatment for breast cancer and melanoma.
Tags: T-Cells Breast Cancer infectious diseases T-cell generation Adoptive Cell Transfer MDSC's cytokines Melanoma -
Methods for treating neoplastic disease in a subject using inorganic Selenium-containing compounds
Provided by:
Stanford University; The Center for Advancing Innovation
Category:
Open Technologies
This technology uses Selenium as a potential chemo and radio sensitizer for colon cancer, lung cancer, and breast melanoma.
Tags: anti-cancer Selenium Se ROS cancer cell apoptosis -
Modulation of Podoplanin mediated platelet activation
Provided by:
Oklahoma Medical Research Foundation (OMRF)
Category:
Open Technologies
Method of inhibiting vascular leakage in central nervous system (CNS) tissues comprised of administering an agonist or mimic of Podoplanin
Tags: central nervous system CNS Podoplanin CLEC-2 receptors vascular leakage -
Mouse Model for the Preclinical Study of Metastatic Disease
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology pertains to a mouse model that shows a pre-clinical therapeutic response of residual metastatic disease.
Tags: neoplasm Carcinoma mouse xenograft metastatic disease -
Mouse Xenograft Model for Mesothelioma
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology is a new mouse model for monoclonal antibodies and immunoconjugates that target malignant mesotheliomas.
Tags: Malignant Mesothelioma asbestos immunoconjugate SS1P GFP-Luciferase fusion proteins Mesothelioma progression -
Murine metastatic pancreatic adenocarcinoma cell lines
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology pertains to orthotopic allograft models for pancreatic cancer that utilize cells or tumor fragments implanted into the cancer-free pancreata of recipient immunocompetent mice.
Tags: Pancreatic Cancer GEM Derived Allograft Mouse Model Adenocarcinoma Inflammation -
Novel Crocetin compound for prevention and therapy of pancreatic cancer
Provided by:
The Center for Advancing Innovation; University of Kansas
Category:
Open Technologies
This technology pertains to Crocetin and how it may inhibit pancreatic cancer cell proliferation and induces apoptosis in pancreatic cancer cells.
Tags: cancer cell apoptosis Crocetin Pancreatic Cancer cancer cell inhibition -
Novel Fusion Proteins for HIV Vaccine
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology pertains to gp120 and CD4-induced antibody fusion proteins for use in an HIV vaccine.
Tags: antibodies HIV Immunogens gp120 CD4 HIV Vaccine fusion protein -
Novel glutathione conjugates for diagnostic and therapeutic use
Provided by:
Oklahoma Medical Research Foundation (OMRF)
Category:
Open Technologies
This technology pertains to the synthesis of S-alanyl-glutathione (glutathionine) in the pathway of sulfur amino acid metabolism.
Tags: CNS glanthionine sulfur amino acid metabolism Lanthionine ketamine derivatives ester amide -
Novel treatments for Multiple Sclerosis (MS)
Provided by:
Oklahoma Medical Research Foundation (OMRF)
Category:
Open Technologies
A potential treatment of MS by decreasing the concentration of adenosine in the brain vasculature or treatment with an adenosine receptor antagonist.
Tags: Multiple Sclerosis MS adenosine adenosine receptor agonist blood brain barrier -
oncolytic herpes simplex virus (oHSV)-Gluc for cancer screening
Provided by:
Research Institute Nationwide Children's Hospital
Category:
Open Technologies
oHSV-Gluc forces tumor cells to secrete Gaussia luciferase (GLuc) as a detectable biomarker
-
Optical Microscope Software for Breast Cancer Diagnosis
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology pertains to diagnostic methods for the detection of breast cancer using spatial genome organization.
Tags: diagnostics Breast Cancer Spatial Genome Organization Cancer detection -
Osmogels: A New Method for Stabilizing Weak Molecular Complex Interactions
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology pertains to the detection of weak molecular complex interactions for research and commercial use.
Tags: diagnostic tool Osmogels Electrophoretic Mobility Shift Assay Polyacrylamide Gel gel -
Particles for imaging
Provided by:
The Center for Advancing Innovation; Washington University - St. Louis
Category:
Open Technologies
This technology pertains to nanoparticles that can be used for imaging and drug delivery simultaneously to potentially treat cancer and heart disease.
Tags: anti-cancer nanoparticles drug vectors heart disease -
Pluripotent stem cell production
Provided by:
Oklahoma Medical Research Foundation (OMRF)
Category:
Open Technologies
Inhibition of the Bright transcription factor to produce pluripotent stem cells that can differentiate into all tissue types
-
Polyclonal Anti-Rat Acetylserotonin Methyltransferase (ASMT)
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology is useful for detecting rat acetylserotonin methyltransferase in immunological assays.
Tags: Acetylserotonin Methyltransferase Immunological Assay -
Polyethylene glycol based oligomers for coating nanoparticles, nanoparticles coated therewith, and related methods
Provided by:
Florida State University; The Center for Advancing Innovation
Category:
Open Technologies
This technology describes nanoparticle coatings that are water dispersible for the treatment of cancer.
Tags: nanoparticles oligomers bioconjugation -
Preparations of poly(lactic-co-glycolic acid)/polydopamine core/shell hybrid nanoparticle for photothermal applications
Provided by:
The Center for Advancing Innovation; University of South Carolina
Category:
Open Technologies
This technology describes a mode of delivery with improved formulation that allows for detecting or treating cancer cells.
-
Promoter substitution for immunoglobin therapy
Provided by:
Oklahoma Medical Research Foundation (OMRF)
Category:
Open Technologies
This technology pertains to immunoglobin (Ig) promoters, in particular murine Ig promoters, to function differentially.
Tags: Bright Transcription factors immunoglobin -
Selective Hsp90ß inhibitors for the treatment of cancer
Provided by:
The Center for Advancing Innovation; University of Kansas
Category:
Open Technologies
This technology pertains to highly selective Hsp90ß inhibitors that can be developed for the treatment of a variety of diseases that result from increased Hsp90 expression.
Tags: anti-cancer Hsp90ß Hsp90ß inhibitors molecular chaperone -
Software System for Analysis of Extremely Large Experimental Dataset and Multidimensional Drug Discovery
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology is a computer software suite that enables its user to investigate extremely large experimental datasets in a simple, yet multidimensional, manner.
Tags: software GPCR Omnimorph multidimensional investigation -
Spatially offset raman spectroscopy of layered soft tissues and application of the same
Provided by:
The Center for Advancing Innovation
Category:
Open Technologies
This technology describes the use of SORS to discriminate multiple layers of soft tissue for identification.
Tags: Breast Cancer SORS spatially offset raman spectroscopy breast conserving therapy BCT -
Spontaneously Transformed Mouse Epithelial Cancer Cell Lines
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology pertains to mouse epithelial cancer cell lines that could be further developed or commercialized.
Tags: Mouse Epithelial Cancer Cell Lines transformation Research Materials -
Stimulation of Toll-like receptors in stem cells
Provided by:
Oklahoma Medical Research Foundation (OMRF)
Category:
Open Technologies
This technology pertains to methods and compositions relating to the identification, stimulation, and repression of stem cells that express Toll-like receptors
Tags: progenitor cells toll-like receptors tissue regeneration tissue grafting hematopoietic stem cells -
System and method for differentiation of normal and malignant in vivo liver tissues
Provided by:
The Center for Advancing Innovation; Vanderbilt University
Category:
Open Technologies
This technology describes the use of NADPH levels to differentiate between healthy and diseased tissue.
Tags: fluorescence NADPH imaging techniques -
Systemic lupus erythematosus (SLE) diagnosis and treatment
Provided by:
Oklahoma Medical Research Foundation (OMRF)
Category:
Open Technologies
Specific genes and combinations thereof that contribute to systemic lupus erythematosus, including methods of diagnosis and treatments targeting those genes.
Tags: systemic lupus erythematosus SLE HLA 6p21 7q32 -
Target for Anti-Tumor Immune Responses
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology pertains to the genotypic and phenotypic analysis of the 888 mel cell line in order to better understand the nature of tumor cells that respond to therapy.
Tags: Melanoma Cancer cell line 888-mel tumor cell response immune response -
Therapoid™ Open Science Platform
Provided by:
Open Therapeutics™
Category:
Open Technologies
The Therapoid™ platform is an online ecosystem which enables members of the biotechnology community to connect, network, and collaborate for the advancement of science.
Tags: alpha features bugs feedback pilot -
Tni-FNL: An Improved Trichoplusia Ni Cell Line for Protein Expression
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology is an improved cell line called Tni-FNL, which is capable of high level expression of heterologous proteins using baculovirus expression systems.
Tags: Cell Line Tni-FNL Baculovirus Insect Cell protein production -
Transgenic Mouse Model of Human Basal Triple Negative Breast Cancer
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology is a characterized transgenic model that is currently an excellent mouse model for TNBC that shares important molecular characteristics of human TNBC.
Tags: Triple-Negative Breast Cancer Prostate Mouse Murine TNBC preclinical testing -
Tumor model for breast cancer cell migration studies and related methods
Provided by:
The Center for Advancing Innovation
Category:
Open Technologies
This technology describes a model pertaining to in vitro drug testing for metastatic cancers.
Tags: Breast Cancer cancer cell encapsulation cancer cell behavioral model -
Tumor Samples Harboring Novel Stem Cell Factor FOXD3 Variants
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology pertains to patient-derived gastrointestinal tumors (GIST) and paraganglioma tumors that harbor genetic mutations that have an effect on early stage embryogenesis.
Tags: Gastrointestinal Tumors GIST Paraganglioma Tumors FOXD3 -
Tumor Tissues Harboring Mutations in cAMP-specific Phosphodiesterases
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology is useful for the investigation of the mechanisms of phosphodiesterase inhibition.
Tags: Biomarkers Endocrine Tumors Phosphodiesterase Inhibitors -
UOK 268 Cell Line for Hereditary Leiomyomatosis and Renal Cell Carcinoma
Provided by:
National Institutes of Health (NIH)
Category:
Open Technologies
This technology uses the UOK 262 immortalized cell line as research tool to study aggressive hereditary leiomyomatosis and renal cell carcinoma (HLRCC) associated with recurring kidney cancer.
Tags: Renal Cell Carcinoma Kidney Cancer Cell Line Leiomyomatosis UOK 268 -
Water soluble G-protein coupled receptor proteins
Provided by:
Oklahoma Medical Research Foundation (OMRF)
Category:
Open Technologies
Methods of making water soluble GPCR proteins that provide a greater surface area for signal transduction.
Tags: G-protein coupled receptor GPCR